Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00528853 · ClinicalTrials.gov registry record
Correlation of Lung Biopsy, BAL, and High Resolution CT Scan in Lung Transplantation
A clinical trial of Bronchiolitis Obliterans Syndrome, sponsored by University of Chicago.
- Completed
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT00528853: Completed study of Bronchiolitis Obliterans Syndrome, sponsored by University of Chicago.
NCT00528853 is a study of Bronchiolitis Obliterans Syndrome that has completed, run by University of Chicago. The registered enrollment target is 10 participants, below the 120-participant average among 5 other Bronchiolitis Obliterans Syndrome trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00528853, a study of Bronchiolitis Obliterans Syndrome, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
A major source of graft failure and dysfunction in lung transplantation is known to be bronchiolitis obliterans (BO)and its clinical correlate called bronchiolitis obliterans syndrome(BOS). In fact, BOS is the leading cause of death in lung recipients beyond one year post transplant. Currently, our ability to assess lung injury after transplant is less than ideal. The purpose of this study is to use new computerized tomography(CT) technology, specifically , 64 bit acquisition, to detect and predict the onset of lung injuries, with the hope of finding better therapies that currently exist.
Conditions Studied
Study Locations (1)
Illinois
- The University of Chicago Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2007-08 |
| Est. Completion | 2009-12 |
What the finished NCT00528853 record still lists
NCT00528853 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 120-participant average among 5 other Bronchiolitis Obliterans Syndrome trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Bronchiolitis Obliterans Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT00528853 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT00528853 about?
NCT00528853 is a clinical study titled "Correlation of Lung Biopsy, BAL, and High Resolution CT Scan in Lung Transplantation". A major source of graft failure and dysfunction in lung transplantation is known to be bronchiolitis obliterans (BO)and its clinical correlate called bronchiolitis obliterans syndrome(BOS). In fact, BOS is the leading cause of death in lung recipients beyond one year post transplant. Currently, our ...
What is the current status of trial NCT00528853?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2007-08. Estimated completion is 2009-12.
What conditions does trial NCT00528853 study?
This clinical trial studies the following conditions: Bronchiolitis Obliterans Syndrome.
Who is sponsoring clinical trial NCT00528853?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00528853 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bronchiolitis Obliterans Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
RECRUITING · Phase 2
-
The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)
RECRUITING
-
LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.
RECRUITING · Phase 2
-
Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation
ACTIVE NOT RECRUITING · Phase 1
-
Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3)
ACTIVE NOT RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia